NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 358 filers reported holding NOVOCURE LTD in Q4 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $17,896 | +5.3% | 244 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $17,000 | +6.2% | 244 | -1.2% | 0.00% | 0.0% |
| Q2 2022 | $16,000 | -15.8% | 247 | -8.9% | 0.00% | 0.0% |
| Q4 2021 | $19,000 | -36.7% | 271 | +3.4% | 0.00% | 0.0% |
| Q3 2021 | $30,000 | -44.4% | 262 | +4.0% | 0.00% | -66.7% |
| Q2 2021 | $54,000 | +42.1% | 252 | -13.7% | 0.00% | +50.0% |
| Q1 2021 | $38,000 | -30.9% | 292 | -8.5% | 0.00% | -50.0% |
| Q4 2020 | $55,000 | +71.9% | 319 | +9.2% | 0.00% | +100.0% |
| Q3 2020 | $32,000 | +23.1% | 292 | -32.9% | 0.00% | 0.0% |
| Q2 2020 | $26,000 | -7.1% | 435 | 0.0% | 0.00% | -33.3% |
| Q1 2020 | $28,000 | +154.5% | 435 | +229.5% | 0.00% | +200.0% |
| Q4 2019 | $11,000 | – | 132 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |